6/24/25 20:29 | 6/23/25 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Reardon Andrew | FL | O | CLO,Secr | S | -57 | 114.08 | 0 | -1 | -2 | 32 | D | | | | | | | | | | | | | | |
6/12/25 17:51 | 6/10/25 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Reardon Andrew | FL | O | CLO,Secr | S | -57 | 114.54 | 0 | -1 | -2 | 32 | D | | | | | | | | | | | | | | |
6/2/25 20:06 | 5/15/25 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Reardon Andrew | FL | O | CLO,Secr | S | -104 | 104.00 | 0 | -1 | -3 | 33 | D | | | | | | | | | | | | | | |
9/25/24 20:54 | 9/23/24 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Reardon Andrew | FL | O | CLO,Secr | M.d | 105 | 52.27 | 0 | 2 | 10 | 23 | D | | | | | | | | | | | | | | |
9/25/24 20:54 | 9/23/24 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Reardon Andrew | FL | O | CLO,Secr | S.d | -199 | 99.60 | 0 | -2 | -8 | 23 | D | | | | | | | | | | | | | | |
8/30/24 20:56 | 8/28/24 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Reardon Andrew | FL | O | CLO,Secr | M.d | 78 | 52.27 | 0 | 2 | 7 | 23 | D | | | | | | | | | | | | | | |
8/30/24 20:56 | 8/28/24 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Reardon Andrew | FL | O | CLO,Secr | S.d | -160 | 106.39 | 0 | -2 | -6 | 23 | D | | | | | | | | | | | | | | |
5/13/24 17:32 | 5/9/24 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Reardon Andrew | FL | O | GC, | M.d | 523 | 52.27 | 0 | 10 | 82 | 22 | D | | | | | | | | | | | | | | |
5/13/24 17:32 | 5/9/24 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Reardon Andrew | FL | O | GC, | S.d | -830 | 83.04 | 0 | -10 | -31 | 22 | D | | | | | | | | | | | | | | |
3/28/23 17:00 | 3/24/23 | LGND | Ligand Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Reardon Andrew | CA | O | See Rema | S | -21 | 69.92 | 0 | 0 | -2 | 16 | D | | | | | | | | | | | | | | |